Skip to content
Exclusive: Sen. Burr on the legacy of Project BioShield and the urgency of PAHPA reauthorization
2001 was the dawn of the modern era of biosecurity in the United States. Following the 9/11 attacks and deadly anthrax letters, the nation […]
3 key priorities shaping the future of U.S. healthcare and biotech
A few topics keep popping up in discussions about the future of U.S. healthcare over the past couple of years. The need to pass
3 key priorities shaping the future of U.S. healthcare and biotech Read More »
Boehringer Ingelheim biomass plant cuts drug maker’s carbon footprint
Biopharma Boehringer Ingelheim took a big step toward achieving the company’s goal of carbon neutrality by 2030 with the July 8 inauguration of a
Boehringer Ingelheim biomass plant cuts drug maker’s carbon footprint Read More »
NIH Innovation Zone 2024: Talus Bio pioneers breakthroughs in ‘undruggable’ transcription factors
Talus Bio’s collaborative and innovative approach to unlocking the therapeutic potential of targeting transcription factors for cancer and other diseases is putting them at
Pride Month 2024: LGBTQ+ biotech leaders celebrate progress, recognize gaps
As 2024 Pride Month concludes, the biotech industry reflects on the critical importance of LGBTQ+ representation and the ongoing efforts to foster inclusivity. The
Pride Month 2024: LGBTQ+ biotech leaders celebrate progress, recognize gaps Read More »
NIH Innovation Zone 2024: Pirouette Medical is innovating safer, easier auto-injections
Injecting medicine can be a scary prospect. It is not just the fear of needles that can prevent patients from self-administration. Even traditional auto-injector
NIH Innovation Zone 2024: Pirouette Medical is innovating safer, easier auto-injections Read More »
Unlocking hope: AMP ALS is transforming ALS biomarker research
“ALS is a devastating disease.” This is a common refrain when talking about Amyotrophic Lateral Sclerosis (ALS), a nervous system disease that weakens muscles
Unlocking hope: AMP ALS is transforming ALS biomarker research Read More »
NIH Innovation Zone 2024: Modality.AI tackles remote neurological assessment
Artificial intelligence (AI) is on everyone’s mind these days. In healthcare and biotech, AI is addressing some of the industry’s biggest challenges, as well
NIH Innovation Zone 2024: Modality.AI tackles remote neurological assessment Read More »
BIO 2024: Can data improve clinical trial diversity?
The COVID pandemic underscored the reality of medical inequity worldwide, a longstanding issue reflected in clinical trials, particularly regarding the absence of race and
BIO 2024: Can data improve clinical trial diversity? Read More »
BIO 2024: Investing in women’s health is an untapped gold mine
Investing in women’s health is a gold mine that few healthcare investors have yet to tap, according to a new study that has come
BIO 2024: Investing in women’s health is an untapped gold mine Read More »